Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Share buy-back week 33/2016


Posted on: 23 Aug 16

Announcement             

22 August 2016

 

Coloplast – transactions in connection with share buy-back programme

 

As mentioned in Announcement No. 4/2016 Coloplast has initiated the first part of the share buy-back programme totalling up to DKK 1bn. The first part of the programme of DKK500m is expected to take place from 29 February, 2016 to 29 August, 2016.

 

The following transactions have been executed during the period 15 August –

19 August 2016:

 

Date Number of shares Buying price Amount DKK
15 August 2016 1,000 530.00 530,000.00
16 August 2016 1,000 517.50 517,500.00
17 August 2016 1,000 509.50 509,500.00
18 August 2016 1,000 513.50 513,500.00
19 August 2016 1,000 510.00 510,000.00
Accumulated until now under the programme 998,750
 
496.33
 
495,708,550.00
 

 

Henceforth, Coloplast owns 4,435,451 treasury B shares of DKK 1 equal to 2.05% of the company’s total share capital.

   

Kind regards,

Investor Relations

Coloplast A/S

Tel. +45 4911 1800

  

For further information, please contact

      

Investors and analysts                              

 

Ellen Bjurgert

Head of Investor Relations

Tel. +45 4911 1800/+45 4911 3376

Email: dkebj@coloplast.com

                                                                 

Press and the media                                 

 

Maria Lindeberg

Sr. Media Relations Manager

Tel. 4911 3095

Email: dkmalg@coloplast.com

 

This announcement is available in a Danish and an English language version. In the event of discrepancies, the Danish version shall prevail.

 

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.

 

Our business includes ostomy care, urology and continence care and wound and skin care. We operate globally and employ more than 10,000 people.

 

The Coloplast logo is a registered trademark of Coloplast A/S. © 2016-08 All rights reserved Coloplast A/S, 3050 Humlebæk, Denmark.

GlobeNewswire
globenewswire.com

Last updated on: 24/08/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.